Document ID: EPA-HQ-OAR-2006-0158-0024
Agency: epa
Document Type: Supporting & Related Material
Title: 
Posted Date: 2006-04-11T04:00Z

Decision
XVII/
5:
Essential­
use
nominations
for
Parties
not
operating
under
paragraph
1
of
Article
5
for
controlled
substances
for
2006
and
2007
Noting
with
appreciation
the
work
done
by
the
Technology
and
Economic
Assessment
Panel
and
its
Medical
Technical
Options
Committee,

Noting
with
appreciation
the
progress
made
since
the
adoption
of
decision
XV/
5
by
Parties
not
operating
under
paragraph
1
of
Article
5
of
the
Montreal
Protocol
in
establishing
a
certain
date
by
which
they
will
cease
submitting
nominations
for
metered­
dose
inhalers
where
the
sole
active
ingredient
is
salbutamol,

Recalling
paragraph
6
of
decision
XV/
5
relating
to
the
phase­
out
of
chlorofluorocarbons
for
metered­
dose
inhalers
where
the
active
ingredient
is
not
solely
salbutamol,

1.
To
authorize
the
levels
of
production
and
consumption
for
2006
and
2007
necessary
to
satisfy
essential
uses
of
chlorofluorocarbons
for
metered­
dose
inhalers
for
asthma
and
chronic
obstructive
pulmonary
disease
as
specified
in
the
annex
to
the
present
decision;

2.
That
Parties
not
operating
under
paragraph
1
of
Article
5
of
the
Montreal
Protocol,
when
licensing,
authorizing,
or
allocating
essential­
use
exemptions
for
chlorofluorocarbons
for
a
manufacturer,
shall
take
into
account
preand
post­
1996
stocks
of
controlled
substances
as
described
in
paragraph
1
(
b)
of
decision
IV/
25,
such
that
no
more
than
a
one­
year
operational
supply
is
maintained
by
that
manufacturer;

3.
With
reference
to
paragraph
6
of
decision
XV/
5,
to
request
that
Parties
not
operating
under
paragraph
1
of
Article
5
of
the
Montreal
Protocol
submit
a
date
to
the
Ozone
Secretariat
prior
to
the
Eighteenth
Meeting
of
the
Parties
by
which
time
a
regulation
or
regulations
to
determine
the
non­
essentiality
of
the
vast
majority
of
chlorofluorocarbons
for
metered­
dose
inhalers
where
the
active
ingredient
is
not
solely
salbutamol
will
have
been
proposed;

Annex
Essential­
use
nominations
for
2006
and
2007
of
chlorofluorocarbons
for
metered­
dose
inhalers
approved
by
the
Seventeenth
Meeting
of
the
Parties
(
metric
tonnes)

Party
2006
2007
Amount
nominated
Amount
approved
Amount
nominated
Amount
approved
European
Community
539
539
­
­
Russian
Federation
400
400
243
243
United
States
of
America
1702
1100
1493
1000